These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2573374)

  • 1. Tertatolol in chronic renal failure. A pharmacokinetic study.
    Rainfray M; Rocher I; Mignon F; Meyrier A
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):266S-277S. PubMed ID: 2573374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of tertatolol with rifampicin and ranitidine pharmacokinetics and antihypertensive activity.
    Kirch W; Milferstädt S; Halabi A; Rocher I; Efthymiopoulos C; Jung L
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):487-91. PubMed ID: 1981019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension.
    Calès P; Caillau H; Crambes O; Vinel JP; Desmorat H; Rocher I; Jung L; Urien S; Brouard R; Pascal JP
    J Hepatol; 1993 Aug; 19(1):43-50. PubMed ID: 7905493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tertatolol in hypertensive patients with chronic renal failure.
    Beaufils M; Lantz B; Paillard F; Richet G
    Am J Nephrol; 1986; 6 Suppl 2():50-4. PubMed ID: 2879474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the enantiomers of tertatolol in the rat after oral and intravenous administration.
    Lave T; Efthymiopoulos C; Van Overloop B; Gairard A; Crambes O; Koffel JC; Jung L
    Xenobiotica; 1994 Jun; 24(6):561-8. PubMed ID: 7975722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure.
    Hannedouche T; Brouard R; Godin M; Kleinknecht D; Paillard F; Grünfeld JP
    Nephrol Dial Transplant; 1991; 6(4):252-6. PubMed ID: 1679214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers.
    Krueger M; Achenbach H; Terhaag B; Haase H; Richter K; Oertel R; Preiss R
    Int J Clin Pharmacol Ther; 2001 Feb; 39(2):61-6. PubMed ID: 11270803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of novel renal properties of tertatolol.
    Guillet C
    Cardiology; 1993; 83 Suppl 1():64-9. PubMed ID: 7903218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertatolol ameliorates renal function in rats with chronic renal failure.
    Delaini F; Perico N; Tagliaferri M; Lupini C; Patino O; Remuzzi G; Garattini S
    J Pharmacol Exp Ther; 1988 Jul; 246(1):287-93. PubMed ID: 2899165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodisposition of tertatolol in man: a review.
    Campbell DB; Chignon JC; Devissaguet JP
    Am J Nephrol; 1986; 6 Suppl 2():61-8. PubMed ID: 3541611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tertatolol on renal function in the isolated perfused rat kidney.
    Perico N; Remuzzi G
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):223S-227S. PubMed ID: 2573368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal effects of intravenous tertatolol in essential arterial hypertension].
    Chaignon M; Brouard R; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance.
    Payton CD; Fox JG; Pauleau NF; Boulton-Jones JM; Ioannides C; Johnston A; Thomas P
    Eur Heart J; 1987 Dec; 8 Suppl M():15-22. PubMed ID: 2897297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICI 141,292 (epanolol)--pharmacokinetics after single and repeated oral administration in the elderly with moderate renal impairment.
    Laher MS; Crome P; Rakhra GS; Ankier SI; Cockshott ID
    Eur J Clin Pharmacol; 1990; 39(1):71-4. PubMed ID: 1980462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F; Lantz B; Leviel F; Ardaillou R
    Am J Nephrol; 1986; 6 Suppl 2():40-4. PubMed ID: 2879472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta blockers induce different intrarenal effects in humans: demonstration by selective infusion of tertatolol and propranolol.
    Nitenberg A; Chemla D; Blanchet F; Guery O; Prost JF; Dutray-Dupagne C
    J Clin Pharmacol; 1990 Oct; 30(10):930-7. PubMed ID: 1977772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function.
    Hartmann C; Frölich M; Krauss D; Spahn-Langguth H; Knauf H; Mutschler E
    Eur J Clin Pharmacol; 1990; 39(6):573-6. PubMed ID: 1982763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redistribution of cardiac output to the kidneys by tertatolol does not involve prostaglandins.
    Naeije R; Degaute JP
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):241S-244S. PubMed ID: 2573371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of tertatolol in biological fluids by gas chromatography-mass spectrometry.
    Staveris S; Blaise P; Efthymiopoulos C; Schneider M; Jamet G; Jung L; Koffel JC
    J Chromatogr; 1985 Apr; 339(1):97-103. PubMed ID: 2862155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.